Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Respiri Ltd RSH


Primary Symbol: RSHUF

Respiri Limited is an Australia-based e-health software-as-a-service (SaaS) company that supports respiratory health management and remote patient monitoring (RPM). It is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. The Wheezo is also used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children (two years and older).


OTCPK:RSHUF - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Aspertheoldmanon Jul 04, 2014 8:40pm
267 Views
Post# 22717709

test 2

test 2
At june 30 2017, the stockholder will have received $1342 in dividend while the bond holder will have received $2025. in interest.
In term of revenues, the bond is better than the stock.
Now for the capital gain.
On june 2017, the conversion price will have been reduced to $10.68 for a ratio of 9.36 shres per bond (because of the dividend)
<< Previous
Bullboard Posts
Next >>